When was Vivolight founded?

Vivolight was founded in 2012 and raised its 1st funding round 12 years after it was founded.

Where is Vivolight located?

Vivolight is headquartered in Shenzhen, China.

Who is the current CEO of Vivolight?

Zhu Rui and Ray s of Vivolight. Zhu Rui has also founded 1 company.

How many employees does Vivolight have?

As of Sep 30, 2026, the latest employee count at Vivolight is 16.

Is Vivolight a funded company?

Vivolight is a funded company, having raised a total of $28.5M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 05, 2024.

When was the latest funding round of Vivolight?

Vivolight's latest funding was a $***** Seed round on Jun 01, 2026, with participation from 3 investors.

Where does Vivolight rank among its competitors?

Vivolight ranks 8th amongst 240 active competitors, of which 63 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was DermaSensor, which secured $4M in Sep, 2026.

Who are the top competitors of Vivolight?

Vivolight's top competitors include Oxford Instruments, DermaSensor and Lucida Medical. Among them, DermaSensor secured the most recent funding round in September, 2026.

Vivolight - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of optical coherence tomography for coronary functional evaluation. The company focuses on the development of medical devices for minimally invasive interventional diagnosis and treatment using laser technology for clinical use.

Website: www.vivolight.com/
Social
Email ID: *****@vivo-light.com
Phone Number: +86 **********

Key Metrics

Founded Year

2012

Location

Shenzhen, China

Stage

Seed

Total Funding

$28.5M in 3 rounds

Latest Funding Round

Seed, Jun 01, 2026, $*****

Investors

Zhejiang Huarui Investment Holdings & 14 more

Ranked

8^th among 240 active competitors

Employee Count

16 as on Sep 30, 2026

Similar Companies

SpectraWAVE & 26 more

View Vivolight's full profile

Vivolight has raised a total funding of $28.5M over 3 rounds. Its first funding round was on Mar 05, 2024. Its latest funding round was a Seed round on Jun 01, 2026 for $*****. 3 investors participated in its latest round. Vivolight has 15 institutional investors.

Here is the list of recent funding rounds of Vivolight:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 01, 2026	5533725	Seed	9123071	4389164	4953407	3018675
Mar 09, 2026	8768999	Seed	4983857	6467752	6427838	BlueRun Ventures & 3 more
Mar 05, 2024	4213901	Seed	7313975	7712039	Zhejiang Huarui Investment Holdings & 1 more	7135725

Access funding benchmarks and valuations. Sign up today!

View details of Vivolight's funding rounds and investors

The founders of Vivolight is Zhu Rui. Zhu Rui and Ray are the CEOs of Vivolight.

Here are the details of Vivolight's key team members:

Zhu Rui: Founder & CEO of Vivolight.
Ray: CEO of Vivolight.

View details of Vivolight's Founder profiles and Board Members

Vivolight's employee count trend

Vivolight has 16 employees as of Sep 26. Here is Vivolight's employee count trend over the years:

Uncover Vivolight's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vivolight include Oxford Instruments, DermaSensor and Lucida Medical. Here is the list of Top 10 competitors of Vivolight, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Oxford Instruments 1959, High Wycombe (United Kingdom), Public	Manufacturer of scientific technology for atomic and molecular level research	-	Europa	69/100
2nd	DermaSensor 2009, Miami (United States), Series B	Developer of an AI-powered skin cancer detection device	$69.7M	Ceros Capital Markets, SternAegis Ventures ... & 11 others	62/100
3rd	Lucida Medical 2019, Cambridge (United Kingdom), Series A	Developer of MRI-based cancer screening technology using artificial intelligence (AI)	$11.5M	prostate-cancer-research.org.uk, IW Capital ... & 23 others	60/100
4th	SpectraWAVE 2012, Waltham (United States), Acquired	Provider of diagnostic photonic imaging	$79.9M	Deerfield, Johnson & Johnson Innovation – JJDC ... & 6 others	59/100
5th	Leica Microsystems 1914, Wetzlar (Germany), Acquired	Manufacturer of microscopes, microscope software, cameras, parts, and accessories	-	SV Health Investors, Westlake Ventures & 1 others	59/100
6th	SciBase 1998, Stockholm (Sweden), Public	Provider of POC device for the detection of malignant melanoma	$22.3M	ÖstVäst Advisory AB, SEB & 5 others	59/100
7th	SamanTree Medical 2014, Lausanne (Switzerland), Series C	Developer of digital microscopy system for high-resolution imaging of tissue	$57.5M	European Investment Bank, Panakes Partners ... & 14 others	59/100
8th	Vivolight 2012, Shenzhen (China), Seed	Developer of optical coherence tomography for coronary functional evaluation	$28.5M	Bank of China, Efung Capital & 13 others	58/100
9th	OncoRes Medical 2014, Perth (Australia), Series B	Developer of intraoperative imaging technology for surgical procedures	$33.1M	Australian Unity, Brandon BioCatalyst & 5 others	57/100
10th	Santec Holdings 1979, Komaki (Japan), Public	Manufacturer of optical instruments, components, and imaging and sensing systems	-	HHS	55/100